Mirtazapine
Product Images NDC 53002-2712

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 53002-2712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022712)

Mirtazapine 45 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label specifies 30 tablets per bottle with instructions to take one tablet daily as directed. Included are the product NDC 53002-2712, barcode, and spaces for patient and clinic information. The label also features standard regulatory and dispensing details.*

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical structure diagram of the active ingredient mirtazapine, showing its fused aromatic rings and chemical bonds in a 2D molecular depiction.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.